<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Cade BE</submitter><funding>NHLBI NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pubmed_abstract>&lt;h4>Rationale&lt;/h4>Multiple pulmonary, sleep, and other disorders are associated with the severity of Covid-19 infections but may or may not directly affect the etiology of acute Covid-19 infection. Identifying the relative importance of concurrent risk factors may prioritize respiratory disease outbreaks research.&lt;h4>Objectives&lt;/h4>To identify associations of common preexisting pulmonary and sleep disease on acute Covid-19 infection severity, investigate the relative contributions of each disease and selected risk factors, identify sex-specific effects, and examine whether additional electronic health record (EHR) information would affect these associations.&lt;h4>Methods&lt;/h4>45 pulmonary and 6 sleep diseases were examined in 37,020 patients with Covid-19. We analyzed three outcomes: death; a composite measure of mechanical ventilation and/or ICU admission; and inpatient admission. The relative contribution of pre-infection covariates including other diseases, laboratory tests, clinical procedures, and clinical note terms was calculated using LASSO. Each pulmonary/sleep disease model was then further adjusted for covariates.&lt;h4>Measurements and main results&lt;/h4>37 pulmonary/sleep diseases were associated with at least one outcome at Bonferroni significance, 6 of which had increased relative risk in LASSO analyses. Multiple prospectively collected non-pulmonary/sleep diseases, EHR terms and laboratory results attenuated the associations between preexisting disease and Covid-19 infection severity. Adjustment for counts of prior "blood urea nitrogen" phrases in clinical notes attenuated the odds ratio point estimates of 12 pulmonary disease associations with death in women by ≥1.&lt;h4>Conclusions&lt;/h4>Pulmonary diseases are commonly associated with Covid-19 infection severity. Associations are partially attenuated by prospectively-collected EHR data, which may aid in risk stratification and physiological studies.</pubmed_abstract><journal>medRxiv : the preprint server for health sciences</journal><pagination>2023.02.19.23286148</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9980259</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of Pulmonary and Sleep Disorders on COVID-19 Infection Severity in a Large Clinical Biobank.</pubmed_title><pmcid>PMC9980259</pmcid><funding_grant_id>R35 HL135818</funding_grant_id><funding_grant_id>U01 HG008685</funding_grant_id><funding_grant_id>R03 HL154284</funding_grant_id><funding_grant_id>R01 HL153805</funding_grant_id><funding_grant_id>P30 AR070253</funding_grant_id><pubmed_authors>Hassan SM</pubmed_authors><pubmed_authors>Cade BE</pubmed_authors><pubmed_authors>Karlson EW</pubmed_authors><pubmed_authors>Mullington JM</pubmed_authors><pubmed_authors>Redline S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of Pulmonary and Sleep Disorders on COVID-19 Infection Severity in a Large Clinical Biobank.</name><description>&lt;h4>Rationale&lt;/h4>Multiple pulmonary, sleep, and other disorders are associated with the severity of Covid-19 infections but may or may not directly affect the etiology of acute Covid-19 infection. Identifying the relative importance of concurrent risk factors may prioritize respiratory disease outbreaks research.&lt;h4>Objectives&lt;/h4>To identify associations of common preexisting pulmonary and sleep disease on acute Covid-19 infection severity, investigate the relative contributions of each disease and selected risk factors, identify sex-specific effects, and examine whether additional electronic health record (EHR) information would affect these associations.&lt;h4>Methods&lt;/h4>45 pulmonary and 6 sleep diseases were examined in 37,020 patients with Covid-19. We analyzed three outcomes: death; a composite measure of mechanical ventilation and/or ICU admission; and inpatient admission. The relative contribution of pre-infection covariates including other diseases, laboratory tests, clinical procedures, and clinical note terms was calculated using LASSO. Each pulmonary/sleep disease model was then further adjusted for covariates.&lt;h4>Measurements and main results&lt;/h4>37 pulmonary/sleep diseases were associated with at least one outcome at Bonferroni significance, 6 of which had increased relative risk in LASSO analyses. Multiple prospectively collected non-pulmonary/sleep diseases, EHR terms and laboratory results attenuated the associations between preexisting disease and Covid-19 infection severity. Adjustment for counts of prior "blood urea nitrogen" phrases in clinical notes attenuated the odds ratio point estimates of 12 pulmonary disease associations with death in women by ≥1.&lt;h4>Conclusions&lt;/h4>Pulmonary diseases are commonly associated with Covid-19 infection severity. Associations are partially attenuated by prospectively-collected EHR data, which may aid in risk stratification and physiological studies.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T21:55:06.15Z</modification><creation>2025-04-04T21:55:06.15Z</creation></dates><accession>S-EPMC9980259</accession><cross_references><pubmed>36865276</pubmed><doi>10.1101/2023.02.19.23286148</doi></cross_references></HashMap>